Advanced search
Publication Cover
Expert Opinion on Drug Safety Volume 19, 2020 - Issue 4: Dermatology
Submit an article Journal homepage
296
Views
4
CrossRef citations to date
0
Altmetric
Drug Safety Evaluation

An update on the safety of apremilast for the treatment of plaque psoriasis

Eran ShavitDivision of Dermatology, Department of Medicine, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada;Dermatology Unit, Barzilai University Medical Center, Ashkelon, Israel;Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheba, IsraelCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-2397-6316View further author information
ORCID Icon &
Neil H. ShearDivision of Dermatology, Department of Medicine, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada;Department of Medicine (Dermatology, Clinical Pharmacology and Toxicology) and Department of Pharmacology, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, CanadaView further author information
Pages 403-408 | Received 26 Jan 2020, Accepted 16 Mar 2020, Published online: 21 Mar 2020

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Jonathan K. Hwang & Shari R. Lipner. (2023) Safety of current systemic therapies for nail psoriasis. Expert Opinion on Drug Safety 22:5, pages 391-406.
Read now

Articles from other publishers (3)

Shekhar NeemaRohit KothariAradhana RoutSiddharth ManiSiddharth BhattSunmeet Sandhu. (2023) Systemic treatment of psoriasis in special population. Indian Journal of Dermatology, Venereology and Leprology 0, pages 1-8.
Crossref
Dmitry A. Verbenko, Arfenya E. Karamova, Olga G. Artamonova, Dmitry G. Deryabin, Alexander Rakitko, Alexandr Chernitsov, Anna Krasnenko, Artem Elmuratov, Victoria S. Solomka & Alexey A. Kubanov. (2020) Apremilast Pharmacogenomics in Russian Patients with Moderate-to-Severe and Severe Psoriasis. Journal of Personalized Medicine 11:1, pages 20.
Crossref
Eleftherios Ntouniadakis & Fredrik Landström. (2020) Pseudotumor of the Larynx: A Previously Unreported Side Effect of Apremilast. Case Reports in Dermatology 12:3, pages 275-281.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.